The invention of the CSRIOs antibiotic is one of Australias greatest achievements, it was mass produced for export in the 1950s and has saved many lives.
What this company should be doing is not try to reduce the use of them but instead contribute to improving antibiotics to be more specific to the ailment and also design them not to affect all of the immune system while in use.
With people like Andrew Forrest as investors there is no excuse why the share price is this low, this company has FDA approval and Forrest should make sure the company is thriving by preventing hedge funds destroying the momentum of any price surges.
It's pityful that he has no knowledge on how to do this, LDX has copped the biggest raw deal of 2024
Add to My Watchlist
What is My Watchlist?
